Thrombocytosis in polymyalgia rheumatica;Die Thrombozytose bei Polymyalgia rheumatica

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 41, 1996, Pages 1255-1260

  Seyfarth, B ^a   Harten, P ^a   Loffler H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BLINDNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; ISCHEMIA; MALE; NEUROPATHY; RHEUMATIC POLYMYALGIA; THROMBOCYTOSIS;

EID: 0029810728     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043136     Document Type: Article

References (39)

1. Barber, H. S.: Myalgic syndrome with constitutional effects. Polymyalgia rheumatica. Ann. rheum. Dis. 16 (1957), 230-237.
2. Bengtsson, B. A., B. E. Malmvall: The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 7 (1981), 899-904.
3. Bird, H., A. W. Esselinckx, A. St. J. Dixon, A. G. Mowat, P. H. Wood: An evaluation of criteria for polymyalgia rheumatica. Ann. rheum. Dis. 38 (1979), 434-439.
4. Böttiger, L. E., C. A. Svedberg: Normal erythrocyte sedimentation rate and age. Brit. med. J. 1967/2, 85-87.
5. Bruce, W.: Senile rheumatic gout. Brit. med. J. 1888/2, 811-813.
6. Caselli, R. J., G. G. Hunder: Neurologic aspects of giant cell (temporal) arteritis (review). Rheum. Dis. Clin. N. Amer. 19 (1993), 941-953.
7. Cid, M. C., G. Ercilla, J. Vilaseca, R. Sanmarti, J. Villalta, M. Ingelmo, A. Urbano-Marquez: Polymyalgia rheumatica. A syndrome associated with HLA-DR4 Antigen. Arthr. Rheum. 31 (1988), 678-682.
8. Cohen, M. D., W. W. Ginsburg: Polymyalgia rheumatica. Rheum. Dis. Clin. N. Amer. 16 (1990), 325-339.
9. Dasgupta, B., G. S. Panayi: Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Brit. J. Rheumatol. 29 (1990), 456-458.
10. De Keyser, J., N. De Klippel, G. Ebinger: Thrombocytosis and ischemic complications in giant cell arteritis. Brit. med. J. 303 (1991), 825.
11. Espinoza, L. R., L. J. Jara, L. H. Silveira, P. Martinez-Osuna, J. B. Zwolinska, C. Kneer, J. L. Aguilar: Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Amer. J. Med. 90 (1991), 474-478.
12. Fauchald, P., O. Rygvold, B. Oystese: Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann. intern. med. 77 (1972), 845-852.
13. Fernandez-Herlihy, L.: Temporal arteritis: clinical aids to diagnosis. J. Rheumatol. 15 (1988), 1797-1802.
14. Frenkel, E. P.: Southwestern Internal Medicine Conference: The clinical spectrum of thrombocytosis and thrombocythemia. Amer. J. med. Sci. 30 (1991), 69-80.
15. Gerber, N. J.: Ein Teilaspekt der Riesenzellarteriitis. Ergebn. inn. Med. Kinderheilk. (1978), 85-149.
16. Günther, R., H. Tischler, M. Herold: Polymyalgia rheumatica. Klinische Beobachtungen an 90 Patienten. Z. Rheumatol. 44 (1985), 218-225.
17. Hamrin, B.: Polymyalgia arteritica. Acta med. scand. 533, Suppl. (1972), 1-164.
18. Häntzschel, H., H. A. Bird, W. Krüger, G. Neumann, G. Schneider, V. Wright: Polymyalgia rheumatica and rheumatoid arthritis of the elderly. A clinical, laboratory and scintigraphic comparison. Ann. rheum. Dis. 50 (1991), 619-622.
19. Healey, L. A.: On the epidemiology of polymyalgia rheumatica and temporal arteritis. J. Rheumatol. 20 (1993), 1639-1640.
20. Hunder, G. G., D. A. Bloch, B. A. Michel, M. B. Stevens, W. P. Arend, L. H. Calabrese, S. M. Edworthy, A. S. Fauci, R. Y. Leavitt, J. T. Lie, R. W. Lightfoot, A. T. Masi, D. J. McShane, J. A. Millis, S. L. Wallace, N. J. Zvaifler: The american college of rheumatology. 1990 criteria for the classification of giant cell arteritis. Arthr. Rheum. 33 (1990), 1122-1128.
21. Jones, J. G., B. L. Hazleman: Prognosis and management of polymyalgia rheumatica. Ann. rheum. Dis. 40 (1981), 1-5.
22. Kutti, J.: The management of thrombocytosis. Europ. J. Haematol. 44 (1990), 81-88.
23. Kyle, V., T. E. Cawston, B. L. Hazleman: ESR and C-reactive protein in assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann. rheum. Dis. 48 (1989), 667-671.
24. Kyle, V.: Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis (review). Baillieres Clin. Rheumatol. 5 (1991), 475-484.
25. Kyle, V., B. L. Hazleman: The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. Ann. rheum. Dis. 52 (1993), 847-850.
26. Lestico, M. R., L. E. Boh, A. A. Schuna: Polymyalgia rheumatica (Review). Clin. Pharm. 12 (1993), 571-580.
27. Liu, G. T., J. S. Glaser, N. J. Schatz, J. L. Smith: Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 101 (1994), 1779-1785.
28. Mitus, A. J., A. I. Schafer: Thrombocytosis and thrombocythemia. Hematol. Oncol. Clin. N. Amer. 4 (1990), 157-165.
29. Olhagen, B.: Polymyalgia rheumatica. Form of senile arteritis. Acta rheum. Scand. 9 (1963), 157-164.
30. Orrell, R. W., M. H. Johnson: Plasma viscosity and the diagnosis of giant cell arteritis. Brit. J. Clin. Pract. 47 (1993), 71-72.
31. Ozsoylu, S., H. S. Strauss, L. K. Diamond: Effects of corticosteroids on coagulation of the blood. Nature (Lond.) 195 (1962), 1214-1215.
32. Persellin, S. T., T. M. Daniels, L. J. Rings: Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica. Mayo Clin. Proc. 60 (1985), 457-460.
33. Price, N., L. G. Clearkin: Thrombocytosis and giant cell arteritis. Lancet 343 (1994), 372.
34. Roche, N. E., J. W. Fulbright, A. D. Wagner, G. G. Hunder, J. J. Goronzy, C. M. Weyand: Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 36 (1993), 1286-1294.
35. Salvarani, C., P. Macchioni, F. Zizzi, W. Mantovani, F. Rossi, C. Castri, N. Cappozoli, R. Baricchi, L. Boiardi, F. Chiaravalloti, I. Portioli: Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthr. Rheum. 34 (1991), 351-356.
36. Tsapatsaris, N. P.: Temporal arteritis. General review with emphasis on atypical and cardiovascular complications (Review). Cardiol. Clin. 9 (1991), 547-553.
37. Valentini, G., U. Chianese, G. Tirri, M. Giordano: Über Thrombozytose bei progredienter Sklerodermie und bei anderen Rheumakrankheiten. Z. Rheumatol. 37 (1978), 233-241.
38. Vigushin, D. M., M. B. Pepys, P. N. Hawkins: Metabolic and scintigraphic studies of radioiodinated human c-reactive protein in health and disease. J. clin. Invest. 91 (1993), 1351-1357.
39. Wagner, A. D., J. J. Gorozny, C. M. Weyand: Functional profile of tissue proliferating and circulating CD68 + cells in giant cell arteritis. Evidence for two components of the disease. Clin. Invest. 94 (1994), 1134-1140.